Incidental Mutation 'R7913:Fgd2'
ID 610695
Institutional Source Beutler Lab
Gene Symbol Fgd2
Ensembl Gene ENSMUSG00000024013
Gene Name FYVE, RhoGEF and PH domain containing 2
Synonyms tcs2, Tcd-2, Tcd2, tcs-2
MMRRC Submission 045961-MU
Accession Numbers
Essential gene? Probably non essential (E-score: 0.235) question?
Stock # R7913 (G1)
Quality Score 225.009
Status Validated
Chromosome 17
Chromosomal Location 29579878-29598509 bp(+) (GRCm39)
Type of Mutation missense
DNA Base Change (assembly) G to T at 29593019 bp (GRCm39)
Zygosity Heterozygous
Amino Acid Change Arginine to Leucine at position 423 (R423L)
Ref Sequence ENSEMBL: ENSMUSP00000024810 (fasta)
Gene Model predicted gene model for transcript(s): [ENSMUST00000024810] [ENSMUST00000123989]
AlphaFold Q8BY35
Predicted Effect probably damaging
Transcript: ENSMUST00000024810
AA Change: R423L

PolyPhen 2 Score 0.996 (Sensitivity: 0.55; Specificity: 0.98)
SMART Domains Protein: ENSMUSP00000024810
Gene: ENSMUSG00000024013
AA Change: R423L

DomainStartEndE-ValueType
RhoGEF 106 289 4.49e-66 SMART
PH 320 420 2.09e-16 SMART
FYVE 450 519 1.07e-28 SMART
PH 545 643 5.09e-6 SMART
Predicted Effect probably benign
Transcript: ENSMUST00000123989
SMART Domains Protein: ENSMUSP00000118828
Gene: ENSMUSG00000024013

DomainStartEndE-ValueType
RhoGEF 106 289 4.49e-66 SMART
Coding Region Coverage
  • 1x: 100.0%
  • 3x: 99.9%
  • 10x: 99.7%
  • 20x: 99.1%
Validation Efficiency 100% (65/65)
MGI Phenotype FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] The protein encoded by this gene belongs to a family of guanine nucleotide exchange factors (GEFs) which control cytoskeleton-dependent membrane rearrangements by activating the cell division cycle 42 (CDC42) protein. This gene is expressed in B lymphocytes, macrophages, and dendritic cells. The encoded protein may play a role in leukocyte signaling and vesicle trafficking in antigen-presenting cells in the immune system. [provided by RefSeq, Oct 2016]
Allele List at MGI
Other mutations in this stock
Total: 56 list
GeneRefVarChr/LocMutationPredicted EffectZygosity
Apaf1 A G 10: 90,896,133 (GRCm39) V324A probably damaging Het
Aqp8 T A 7: 123,063,495 (GRCm39) I115N possibly damaging Het
Atrn G A 2: 130,812,131 (GRCm39) C692Y probably damaging Het
Card10 A T 15: 78,665,303 (GRCm39) S717T possibly damaging Het
Cep78 T C 19: 15,947,941 (GRCm39) S408G probably benign Het
Col24a1 G T 3: 145,137,621 (GRCm39) G895* probably null Het
Cs A T 10: 128,186,310 (GRCm39) K34N possibly damaging Het
Dchs1 T C 7: 105,408,435 (GRCm39) E1799G possibly damaging Het
Dlg5 A T 14: 24,187,192 (GRCm39) probably null Het
Dpy19l4 A T 4: 11,265,859 (GRCm39) Y696* probably null Het
Dync1h1 A T 12: 110,595,168 (GRCm39) N1360I probably benign Het
Fmo4 T C 1: 162,621,741 (GRCm39) D490G possibly damaging Het
Gm5113 A T 7: 29,877,648 (GRCm39) probably benign Het
Grid1 T A 14: 35,291,654 (GRCm39) W854R probably damaging Het
H2-M1 T C 17: 36,981,129 (GRCm39) probably null Het
Hivep1 T A 13: 42,309,842 (GRCm39) M694K probably benign Het
Hsd17b6 T C 10: 127,833,645 (GRCm39) T79A possibly damaging Het
Hspa4 A C 11: 53,153,134 (GRCm39) V761G probably benign Het
Ifi203 T C 1: 173,754,523 (GRCm39) Y736C probably damaging Het
Mettl9 T A 7: 120,675,524 (GRCm39) L308Q probably damaging Het
Miox A G 15: 89,220,785 (GRCm39) D230G probably damaging Het
Ncapd3 T A 9: 26,959,522 (GRCm39) C319* probably null Het
Ncs1 C A 2: 31,177,296 (GRCm39) probably null Het
Nell1 T A 7: 49,929,270 (GRCm39) H392Q possibly damaging Het
Nlrp1b C A 11: 71,108,537 (GRCm39) E321D possibly damaging Het
Nlrp9b A T 7: 19,779,725 (GRCm39) H796L probably benign Het
Nudt16l1 C A 16: 4,757,245 (GRCm39) Q53K possibly damaging Het
Nyap1 A G 5: 137,733,231 (GRCm39) S601P probably damaging Het
Odf2l C T 3: 144,859,244 (GRCm39) Q634* probably null Het
Or10al2 A T 17: 37,982,999 (GRCm39) E28D probably benign Het
Or12e14 A G 2: 87,677,037 (GRCm39) I141V probably benign Het
Or1e22 A G 11: 73,377,224 (GRCm39) V142A probably benign Het
Or5ac23 C T 16: 59,149,606 (GRCm39) D89N possibly damaging Het
Or5b120 T A 19: 13,480,571 (GRCm39) V288E probably damaging Het
Or5m10 T A 2: 85,718,074 (GRCm39) L310H probably damaging Het
Peg3 GTGGGGCTCCTGGCCATGGGGCTTATCATCATGGGGCTCCTGGCCATGGGGCTTATCATCATGGGGCTCCTGGCCATGGGGCTTATCATCATGGGGCTC GTGGGGCTCCTGGCCATGGGGCTTATCATCATGGGGCTCCTGGCCATGGGGCTTATCATCATGGGGCTC 7: 6,712,167 (GRCm39) probably benign Het
Pik3c2b T C 1: 133,017,799 (GRCm39) probably null Het
Pramel21 T A 4: 143,341,615 (GRCm39) Y15N possibly damaging Het
Prl3c1 A G 13: 27,383,393 (GRCm39) I40V probably benign Het
R3hdm4 C T 10: 79,747,779 (GRCm39) A229T probably damaging Het
Rab3gap2 T C 1: 184,995,013 (GRCm39) S851P possibly damaging Het
Ralgapb A T 2: 158,307,859 (GRCm39) I1056F probably damaging Het
Sec16b T C 1: 157,356,899 (GRCm39) Y36H probably benign Het
Setd3 A T 12: 108,073,924 (GRCm39) V451D probably benign Het
Slc35e1 T C 8: 73,238,506 (GRCm39) K334R probably damaging Het
Synj1 A T 16: 90,788,315 (GRCm39) N184K possibly damaging Het
Syt1 T C 10: 108,478,109 (GRCm39) D105G probably benign Het
Taar7e T A 10: 23,913,902 (GRCm39) C131S possibly damaging Het
Tead4 A G 6: 128,220,331 (GRCm39) probably null Het
Tescl C A 7: 24,033,076 (GRCm39) R83L probably damaging Het
Ufd1 G T 16: 18,633,616 (GRCm39) V14F probably benign Het
Ugt1a10 T A 1: 87,983,477 (GRCm39) Y92N probably benign Het
Vmn2r52 C A 7: 9,896,877 (GRCm39) V532L probably benign Het
Vmn2r67 G A 7: 84,801,036 (GRCm39) T300I possibly damaging Het
Wt1 T G 2: 104,997,205 (GRCm39) S381A probably damaging Het
Zbtb44 C T 9: 30,965,504 (GRCm39) Q305* probably null Het
Other mutations in Fgd2
AlleleSourceChrCoordTypePredicted EffectPPH Score
IGL01397:Fgd2 APN 17 29,586,949 (GRCm39) missense probably damaging 1.00
IGL01505:Fgd2 APN 17 29,585,971 (GRCm39) missense probably damaging 1.00
IGL03240:Fgd2 APN 17 29,580,135 (GRCm39) splice site probably benign
ceci UTSW 17 29,587,350 (GRCm39) splice site probably null
R0046:Fgd2 UTSW 17 29,593,964 (GRCm39) splice site probably benign
R0271:Fgd2 UTSW 17 29,585,982 (GRCm39) missense possibly damaging 0.94
R0594:Fgd2 UTSW 17 29,584,526 (GRCm39) missense probably damaging 1.00
R0612:Fgd2 UTSW 17 29,597,321 (GRCm39) missense probably benign 0.45
R1470:Fgd2 UTSW 17 29,593,082 (GRCm39) splice site probably benign
R1551:Fgd2 UTSW 17 29,597,383 (GRCm39) missense probably damaging 1.00
R1596:Fgd2 UTSW 17 29,595,904 (GRCm39) missense probably benign 0.43
R1664:Fgd2 UTSW 17 29,588,273 (GRCm39) missense probably damaging 1.00
R1689:Fgd2 UTSW 17 29,582,696 (GRCm39) missense probably benign
R1691:Fgd2 UTSW 17 29,597,918 (GRCm39) nonsense probably null
R1695:Fgd2 UTSW 17 29,587,219 (GRCm39) missense possibly damaging 0.88
R2697:Fgd2 UTSW 17 29,595,895 (GRCm39) missense probably damaging 1.00
R3500:Fgd2 UTSW 17 29,584,575 (GRCm39) missense possibly damaging 0.74
R3689:Fgd2 UTSW 17 29,597,924 (GRCm39) missense probably benign 0.00
R4583:Fgd2 UTSW 17 29,586,052 (GRCm39) missense possibly damaging 0.87
R4871:Fgd2 UTSW 17 29,592,223 (GRCm39) missense possibly damaging 0.89
R5011:Fgd2 UTSW 17 29,593,954 (GRCm39) critical splice donor site probably null
R5209:Fgd2 UTSW 17 29,587,350 (GRCm39) splice site probably null
R7106:Fgd2 UTSW 17 29,595,944 (GRCm39) nonsense probably null
R7139:Fgd2 UTSW 17 29,592,229 (GRCm39) missense probably damaging 1.00
R7712:Fgd2 UTSW 17 29,595,886 (GRCm39) missense probably benign 0.01
R7833:Fgd2 UTSW 17 29,586,369 (GRCm39) missense possibly damaging 0.81
R7834:Fgd2 UTSW 17 29,583,925 (GRCm39) missense probably damaging 1.00
R8547:Fgd2 UTSW 17 29,583,934 (GRCm39) missense probably damaging 0.99
R8686:Fgd2 UTSW 17 29,597,997 (GRCm39) missense probably benign
R9088:Fgd2 UTSW 17 29,583,913 (GRCm39) missense probably damaging 1.00
R9525:Fgd2 UTSW 17 29,583,955 (GRCm39) missense probably damaging 1.00
R9601:Fgd2 UTSW 17 29,593,860 (GRCm39) missense probably benign 0.09
Z1177:Fgd2 UTSW 17 29,597,300 (GRCm39) missense probably benign 0.05
Predicted Primers PCR Primer
(F):5'- AGGACTTGGTTTGGCATGTATAAC -3'
(R):5'- AGACACATACCGCTAACTAGGG -3'

Sequencing Primer
(F):5'- CATGTATAACCTGGAGCTGATAGC -3'
(R):5'- TACCGCTAACTAGGGAACTCTGG -3'
Posted On 2019-12-20